New Australian Government data of organ and tissue donation shows eye donations are up 12% year-on-year, but a leading eye bank director says stress on the health system is contributing to lower rates compared to pre-pandemic levels. Read more
Zeiss and Precise Bio to accelerate bio-fabricated corneal tissue program
Carl Zeiss Meditec has revealed a new partnership with Precise Bio to develop fabricated corneal tissue, leveraging a new 4D bio-fabrication platform that is set to address a major unmet need in ophthalmology. Read more
Latest developments in keratoconus to be explored at KeraClub 2022
Ground-breaking research and the latest developments in keratoconus will be shared next month at KeraClub 2022, a hybrid event for people with the condition, their families, and carers. Read more
Macular Disease Foundation Australia appoints Dr Kathy Chapman as CEO
Macular Disease Foundation Australia (MDFA) has appointed Dr Kathy Chapman as its new CEO, taking over the role from Ms Dee Hopkins, who departed in June after leading the organisation for the past five years. Read more
Optometry Australia CEO Lyn Brodie tenders resignation
Optometry Australia (OA) CEO Ms Lyn Brodie has tended her resignation after five years at the helm of the national peak body. Read more
RANZCO partnership to benefit Māori eye health
The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) and Kāpo Māori Aotearoa (KMA) in New Zealand have formed a partnership to benefit Māori eye health. Read more
ProVision national conference returns bigger than ever
Independent optometry network ProVision has revealed details for its upcoming national conference that – for the first time in its 30-plus-year history – will open invitations to non-member optometrists and students. Read more
Vabysmo recommended for PBS as two-year trial confirms fewer treatments for wet AMD
Australian health authorities have approved novel drug Vabysmo for listing on the PBS, as its manufacturer released two-year data confirming the therapy can improve vision with fewer treatments for people with neovascular age-related macular degeneration (nAMD). Read more
Manufacturer explains why it sought controversial revocation of eyewear tariff concession
The Australian frames maker who prompted the removal of a 5% tariff concession enjoyed by acetate eyewear importers has detailed its rationale behind the decision, hoping it will make people stop and think about engaging local manufacturing options. Read more
First glimpse of ZEISS innovations at Australian Experience Showcase events
ZEISS ANZ recently held three Experience Showcase events across Sydney, Melbourne, and Brisbane, featuring its expansive product portfolio and the first showing of its latest innovations in phacoemulsification and femtosecond laser technology. Read more